Sanofi (SNY) Income from Continuing Operations (2009 - 2026)

Sanofi has disclosed Income from Continuing Operations across 18 years of filings, most recently posting 3183257422.56 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 3183257422.56, up 1.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 12508708619.46 (down 6.68% YoY), and the FY2025 annual result was 5973871317.43, up 1.75% from the prior year.
• Income from Continuing Operations came in at 3183257422.56 for Q1 2026 at Sanofi, up from 3714462855.4 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 10943524710.14 in Q3 2025 to a low of 3714462855.4 in Q4 2025.
• The 5-year median for Income from Continuing Operations is 3161625352.61 (2022), against an average of 3707718433.73.
• Across the five-year window, Income from Continuing Operations surged 2204.94% in 2022 and sank 221.97% in 2025, its largest moves.
• Sanofi's Income from Continuing Operations stood at 6681599995.33 in 2022, then jumped by 49.28% to 9973962956.26 in 2023, then tumbled by 69.47% to 3045496890.46 in 2024, then sank by 221.97% to 3714462855.4 in 2025, then jumped by 185.7% to 3183257422.56 in 2026.
• The last three Income from Continuing Operations figures came in at 3183257422.56 (Q1 2026), 3714462855.4 (Q4 2025), and 10943524710.14 (Q3 2025), per Business Quant data.